Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.5B | 2.0B | 2.3B | 1.2B |
| Cost of revenue | 426.2M | 502.6M | 555.2M | 349.5M |
| Gross profit | 1.1B | 1.5B | 1.7B | 855.7M |
| Operating expense | ||||
| Research & development | 387.3M | 355.4M | 368.7M | 377.4M |
| Selling general and admin | 409.0M | 442.0M | 350.2M | 317.4M |
| Other operating expenses | 308.0M | -5.9M | -19.4M | -5.2M |
| Operating income | -33.4M | 740.2M | 1.0B | 166.0M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 20.5M | 20.5M | 20.5M | 20.5M |
| Other income expense | 1.9B | -637.2M | 500.4M | -76.9M |
| Pretax income | 1.8B | 82.5M | 1.5B | 68.6M |
| Tax provision | 394.9M | 16.8M | 205.7M | -6.9M |
| Net income | 1.4B | 65.6M | 1.3B | 75.5M |
| Basic EPS | 5.6 | 0.3 | 5.1 | 0.3 |
| Diluted EPS | 5.1 | 0.2 | 4.7 | 0.3 |
| Basic average shares | 255.2M | 253.9M | 251.5M | 248.8M |
| Diluted average shares | 278.9M | 271.3M | 276.8M | 267.4M |
| EBITDA | 16.1M | 791.9M | 1.1B | 232.4M |
| Net income from continuing op. | 1.4B | 65.6M | 1.3B | 75.5M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | — | — |